Natural antibiosis among skin bacteria as a primary defence against infection

The British Journal of Dermatology
S Selwyn

Abstract

Antibiotic-producing bacteria were present on the healthy intact skin of 77 of 340 people but predominated in only 38-9% of these. In contrast, antibiotic-producers which occurred in the lesions of 51 out of 263 dermatological patients predominated in 78-4%. The presence of inhibitory commensals in skin lesions was associated with a significantly low incidence of secondary infection both on admission and during hospital stay; there was, however, a small excess of Gram-negative infections on admission in skin lesions containing antibiotic producers. Among ninety surgical patients, also, the presence of inhibitory skin bacteria was associated with a relatively low rate of wound colonization by pathogenic bacteria. The ecological implications and practical applications of the findings are discussed.

References

Jan 1, 1972·The Journal of Pharmacy and Pharmacology·J Burns, B G Robbins
Jan 15, 1972·British Medical Journal·S Selwyn, H Ellis
Feb 1, 1967·The Journal of Experimental Medicine·B F Anthony, L W Wannamaker
Feb 1, 1968·The British Journal of Dermatology·N M Evans
Jul 1, 1965·The British Journal of Dermatology·S SELWYN, D CHALMERS
Mar 1, 1965·Journal of General Microbiology·A C BAIRD-PARKER

❮ Previous
Next ❯

Citations

Jul 1, 1995·Clinics in Dermatology·K Chikakane, H Takahashi
Nov 25, 2003·The Journal of Hospital Infection·E Kownatzki
Feb 24, 1998·Clinics in Dermatology·J H Cove, E A Eady
Jul 8, 1982·The New England Journal of Medicine·P A Mackowiak
Dec 1, 1994·Pediatric Dermatology·G L Darmstadt, A T Lane
Apr 1, 1985·Antimicrobial Agents and Chemotherapy·R SutherlandA R White
Dec 18, 1976·British Medical Journal·W BrumfittJ Cooper
Feb 1, 1978·Journal of Clinical Pathology·W T SpeckH S Rosenkranz
Dec 1, 1978·The British Journal of Venereal Diseases·M E McBrideJ M Knox
Dec 10, 1977·British Medical Journal
Oct 2, 1976·British Medical Journal
Mar 1, 1978·The British Journal of Dermatology·D G Pitcher
Jan 1, 1977·Journal of Cutaneous Pathology·M E McBrideJ M Knox
Apr 6, 2011·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Mariana RosenthalBetsy Foxman
Mar 1, 1991·The Journal of Hospital Infection·D J ByrneA Cuschieri
Jun 1, 1991·The Journal of Hospital Infection·S Selwyn
Jun 1, 1988·The Journal of Applied Bacteriology·B KumarS Sharma
Dec 1, 1981·The Journal of Applied Bacteriology·A M Al-Admawy, W C Noble
Jul 1, 1983·Clinics in Dermatology·B Terleckyj, D A Axler
Jan 1, 2013·Pathogens·Mariana RosenthalBetsy Foxman
Jun 1, 1978·Applied and Environmental Microbiology·D J BibelD J Lovell
Aug 1, 1979·The American Journal of Medicine·P A Mackowiak
Mar 1, 1989·Journal of the American Academy of Dermatology·R R Roth, W D James
Apr 1, 1987·Zentralblatt Für Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology·G PulvererF Schumacher-Perdreau

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.